Yulia Lin

Summary

Affiliation: Sunnybrook Health Sciences Centre
Country: Canada

Publications

  1. pmc The utility of recombinant factor VIIa as a last resort in trauma
    Rishi Mamtani
    Trauma Services, Division of General Surgery, Sunnybrook Health Sciences Centre and Canadian Forces Health Services, 2075 Bayview Avenue, Room H1 86, Toronto, ON M4N 3M5, USA
    World J Emerg Surg 7:S7. 2012
  2. pmc The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
    Y Lin
    Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Ontario, Canada
    Transfus Med 22:383-94. 2012
  3. pmc Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis
    Yulia Lin
    Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Toronto, Toronto, Ont, Canada
    CMAJ 183:E9-19. 2011
  4. pmc Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial
    Bartolomeu Nascimento
    Department of General Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
    CMAJ 185:E583-9. 2013
  5. doi request reprint Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
    Ewurabena Simpson
    Department of Paediatrics, Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 3:CD005011. 2012
  6. doi request reprint Design and preliminary results of a pilot randomized controlled trial on a 1:1:1 transfusion strategy: the trauma formula-driven versus laboratory-guided study
    Bartolomeu Nascimento
    Department of Surgery, Tory Regional Trauma Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
    J Trauma 71:S418-26. 2011
  7. pmc Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients
    Bartolomeu Nascimento
    Tory Regional Trauma Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada
    Clinics (Sao Paulo) 66:101-6. 2011
  8. doi request reprint Hospital-based transfusion error tracking from 2005 to 2010: identifying the key errors threatening patient transfusion safety
    Carolyn Maskens
    University of British Columbia, Vancouver, British Columbia, Canada Laboratory Medicine, The Department of Clinical Pathology, and the Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
    Transfusion 54:66-73; quiz 65. 2014
  9. ncbi request reprint Cryoprecipitate: the current state of knowledge
    Jeannie L Callum
    Sunnybrook Health Sciences Centre and University Health Network, Toronto, Ontario, Canada
    Transfus Med Rev 23:177-88. 2009
  10. ncbi request reprint A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload
    Lani Lieberman
    Department of Clinical Pathology, University Health Network, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
    Transfus Med Rev 27:206-12. 2013

Collaborators

Detail Information

Publications17

  1. pmc The utility of recombinant factor VIIa as a last resort in trauma
    Rishi Mamtani
    Trauma Services, Division of General Surgery, Sunnybrook Health Sciences Centre and Canadian Forces Health Services, 2075 Bayview Avenue, Room H1 86, Toronto, ON M4N 3M5, USA
    World J Emerg Surg 7:S7. 2012
    ..The objective of this study was to identify critical degrees of acidosis and associated factors at which rFVIIa might be considered of no utility...
  2. pmc The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
    Y Lin
    Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Ontario, Canada
    Transfus Med 22:383-94. 2012
    ....
  3. pmc Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis
    Yulia Lin
    Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Toronto, Toronto, Ont, Canada
    CMAJ 183:E9-19. 2011
    ..The benefits and risks of off-label use of recombinant factor VIIa in patients without hemophilia are contested. We performed a systematic review to assess the effectiveness and safety of such use...
  4. pmc Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial
    Bartolomeu Nascimento
    Department of General Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
    CMAJ 185:E583-9. 2013
    ..We conducted a randomized controlled trial to assess the feasibility of a 1:1:1 transfusion protocol and its effect on mortality and complications among patients with severe trauma...
  5. doi request reprint Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
    Ewurabena Simpson
    Department of Paediatrics, Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 3:CD005011. 2012
    ..This is the third version of the 2007 Cochrane review on the use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia, and has been updated to incorporate recent trial data...
  6. doi request reprint Design and preliminary results of a pilot randomized controlled trial on a 1:1:1 transfusion strategy: the trauma formula-driven versus laboratory-guided study
    Bartolomeu Nascimento
    Department of Surgery, Tory Regional Trauma Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
    J Trauma 71:S418-26. 2011
    ..However, a randomized controlled trial on the topic is lacking. We report on the design and preliminary results of our ongoing randomized control pilot trial (ClinicalTrial.gov NCT00945542)...
  7. pmc Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients
    Bartolomeu Nascimento
    Tory Regional Trauma Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada
    Clinics (Sao Paulo) 66:101-6. 2011
    ..To determine whether recombinant factor VIIa (rFVIIa) is associated with increased survival and/or thromboembolic complications...
  8. doi request reprint Hospital-based transfusion error tracking from 2005 to 2010: identifying the key errors threatening patient transfusion safety
    Carolyn Maskens
    University of British Columbia, Vancouver, British Columbia, Canada Laboratory Medicine, The Department of Clinical Pathology, and the Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
    Transfusion 54:66-73; quiz 65. 2014
    ..This report provides a comprehensive analysis of transfusion errors occurring at a large teaching hospital and aims to determine key errors that are threatening transfusion safety, despite implementation of safety measures...
  9. ncbi request reprint Cryoprecipitate: the current state of knowledge
    Jeannie L Callum
    Sunnybrook Health Sciences Centre and University Health Network, Toronto, Ontario, Canada
    Transfus Med Rev 23:177-88. 2009
    ..Despite 45 years of the use of this product, we still have a lot to learn regarding the optimal use of cryoprecipitate...
  10. ncbi request reprint A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload
    Lani Lieberman
    Department of Clinical Pathology, University Health Network, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
    Transfus Med Rev 27:206-12. 2013
    ..Suboptimal ordering and infusion practices may be contributing to the high incidence and severity of TACO. Research in TACO prevention strategies, such as slow rates of infusion and preemptive diuretics, is warranted. ..
  11. doi request reprint The prevention of transfusion-associated circulatory overload
    Asim Alam
    Department of Anesthesia and Pain Medicine, Hospital for Sick Children, Toronto, Ontario, Canada
    Transfus Med Rev 27:105-12. 2013
    ..We believe that using these methodologies on a global scale will prevent many TACO events and minimize the severity when it does occur...
  12. ncbi request reprint Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
    Yulia Lin
    Department of Clinical Pathology, Sunnybrook Health Sciences Centre and Canadian Blood Services, 2075 Bayview Avenue, Room B204, Toronto, Ontario, Canada, M4N 3M5
    Cochrane Database Syst Rev 2:CD005011. 2011
    ..It is also increasingly being used for off-license indications to prevent bleeding in operations where blood loss is likely to be high, and/or to stop bleeding that is proving difficult to control by other means...
  13. doi request reprint Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of literature
    Amanda Squires
    NICU at Sunnybrook Health Sciences Center, Toronto, Canada
    Neonatal Netw 31:69-80. 2012
    ..A positive DAT should alert the clinician to the presence of maternal antibodies against low-incidence antigens. Antibodies to the Wra antigen are one such rare cause of HDN...
  14. pmc Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers
    Bartolomeu Nascimento
    Transfusion Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, C160, Toronto, ON M4N 3M5, Canada
    Crit Care 14:202. 2010
    ....
  15. doi request reprint Transfusion-associated hyperkalemia
    Adrienne Vraets
    Transfusion Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, Ontario, Canada
    Transfus Med Rev 25:184-96. 2011
    ....
  16. ncbi request reprint Cellular therapies: a Canadian blood services research and development symposium
    Nadine Shehata
    Division of Hematology, St Michael s Hospital, Toronto, Canada
    Transfus Med Rev 21:317-36. 2007
  17. ncbi request reprint Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients
    Yulia Lin
    Department of Clinical Pathology, Sunnybrook and Women s College Health Sciences Center, Toronto, Ontario, Canada
    Transfusion 42:166-72. 2002
    ..The impact of platelet and plasma incompatibility on clinical outcomes was analyzed...